128 related articles for article (PubMed ID: 31977536)
1. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
Mandurino-Mirizzi A; Demarchi A; Ruffinazzi M; Cornara S; Somaschini A; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona Visconti L; De Ferrari GM
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):337-339. PubMed ID: 31977536
[No Abstract] [Full Text] [Related]
2. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
[TBL] [Abstract][Full Text] [Related]
3. Leptin affects the inflammatory response after STEMI.
Demarchi A; Mazzucchelli I; Somaschini A; Cornara S; Dusi V; Mirizzi AM; Ruffinazzi M; Crimi G; Ferlini M; Gnecchi M; Visconti LO; De Servi S; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):922-924. PubMed ID: 32249141
[TBL] [Abstract][Full Text] [Related]
4. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
[TBL] [Abstract][Full Text] [Related]
5. Plaque characteristics and inflammatory markers for the prediction of major cardiovascular events in patients with ST-segment elevation myocardial infarction.
Her AY; Cho KI; Singh GB; An DS; Jeong YH; Koo BK; Shin ES
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1445-1454. PubMed ID: 28555389
[TBL] [Abstract][Full Text] [Related]
6. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
[TBL] [Abstract][Full Text] [Related]
7. The functional effect of atorvastatin dose-dependent via inflammation factors on acute ST segment elevation myocardial infarction after emergency percutaneous coronary intervention.
Liu Q; Wang Y; Cheng X
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):215-219. PubMed ID: 30222665
[TBL] [Abstract][Full Text] [Related]
8. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Park Y; Tantry US; Koh JS; Ahn JH; Kang MG; Kim KH; Jang JY; Park HW; Park JR; Hwang SJ; Park KS; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
Thromb Haemost; 2017 May; 117(5):911-922. PubMed ID: 28150852
[TBL] [Abstract][Full Text] [Related]
9. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
Çınar T; Çağdaş M; Rencüzoğulları İ; Karakoyun S; Karabağ Y; Yesin M; Sadioğlu Çağdaş Ö; Tanboğa Hİ
Scand Cardiovasc J; 2019 Apr; 53(2):83-90. PubMed ID: 30835559
[TBL] [Abstract][Full Text] [Related]
10. Post-cardiac injury syndrome in acute myocardial infarction patients undergoing PCI: a case report and literature review.
Gao Y; Bishopric NH; Chen HW; Li JT; Huang YL; Huang HX
BMC Cardiovasc Disord; 2018 Dec; 18(1):234. PubMed ID: 30541442
[TBL] [Abstract][Full Text] [Related]
11. Impact of adherence to a Mediterranean Diet pattern on patients with first acute myocardial infarction.
Magnoni M; Scarano P; Vergani V; Berteotti M; Gallone G; Cristell N; Maseri A; Cianflone D
Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):574-580. PubMed ID: 32007333
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.
Abouzaki NA; Christopher S; Trankle C; Van Tassell BW; Carbone S; Mauro AG; Buckley L; Toldo S; Abbate A
J Cardiovasc Pharmacol; 2018 Jun; 71(6):375-379. PubMed ID: 29634656
[TBL] [Abstract][Full Text] [Related]
13. The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'?
Somaschini A; Cornara S; Demarchi A; Mandurino-Mirizzi A; Baldi E; Ferlini M; Crimi G; Camporotondo R; Gnecchi M; Oltrona Visconti L; De Ferrari GM
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):340-342. PubMed ID: 31972747
[No Abstract] [Full Text] [Related]
14. Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction.
Groot HE; Al Ali L; van der Horst ICC; Schurer RAJ; van der Werf HW; Lipsic E; van Veldhuisen DJ; Karper JC; van der Harst P
Clin Res Cardiol; 2019 Jun; 108(6):612-621. PubMed ID: 30367209
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in ST- elevation myocardial infarction: risk factors, patterns of presentation and association with clinical picture and outcome, an observational study conducted at the Institute of Cardiology-National Hospital of Sri Lanka.
Navinan MR; Mendis S; Wickramasinghe S; Kathirgamanathan A; Fernando T; Yudhisdran J
BMC Cardiovasc Disord; 2019 May; 19(1):111. PubMed ID: 31088357
[TBL] [Abstract][Full Text] [Related]
16. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y
Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
[TBL] [Abstract][Full Text] [Related]
18. Effect of a combination of antiplatelet and antithrombotic pretreatment on myocardial perfusion in patients with an acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Prech M; Bartela E; Janus M; Jeremicz I; Araszkiewicz A; Urbanska L; Pyda M; Grajek S
Coron Artery Dis; 2016 Nov; 27(7):580-5. PubMed ID: 27228184
[TBL] [Abstract][Full Text] [Related]
19. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity.
Shacham Y; Steinvil A; Arbel Y
J Nephrol; 2016 Apr; 29(2):169-174. PubMed ID: 26861658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
